Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.023 USD | -0.14% | -10.15% | +6.87% |
05-14 | Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza as Chief Medical Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.87% | 27.27M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.66% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- Sector Update: Health Care